Universal Oncocare Private Limited
About Universal Oncocare Private Limited
Data last updated:
Universal Oncocare Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 28 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2020PTC348921.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Mishil Sandeep Parikh and Tushar Sambhaji Jadhav.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 2nd Floor Plot 7 Sharda Sadan Swami Gyanjivandas Marg Dadar (East), Mumbai, Maharashtra, India – 400014.
As per the financials filed for FY 2022, the company reported a revenue of ₹11.46 Lakh. For the same year it recorded a net profit of ₹7 Lakh (net margin 61.1%) and EBITDA of ₹8.35 Lakh (EBITDA margin 72.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address2nd Floor Plot 7 Sharda Sadan Swami Gyanjivandas Marg Dadar (East), Mumbai, Maharashtra, India – 400014
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Universal Oncocare Private Limited
The main business activity of Universal Oncocare is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Universal Oncocare Private Limited FY 2022 filings available
Universal Oncocare Private Limited reported revenue of ₹11.46 Lakh for FY 2022.
Financial Statement Summary of Universal Oncocare Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹8.35 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹7 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Universal Oncocare Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 72.9% | •••• |
| Net Profit Margin | 61.1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Universal Oncocare are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Universal Oncocare Private Limited
Universal Oncocare Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Doctorslab Medical Services Private Limited | ₹11.66 Lakh (FY 2023) | •••• | •••• | 163.0% | •••• | Hyderabad, Telangana, India |
| Helixer Health Care Private Limited | ₹11.61 Lakh (FY 2019) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| DBR Diagnostics Services Private Limited | ₹11.57 Lakh (FY 2024) | •••• | •••• | -69.0% | •••• | Hyderabad, Telangana, India |
| Noida Diagnostics Private Limited | ₹11.52 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Physico Radiology Tech Private Limited | ₹11.51 Lakh (FY 2022) | •••• | •••• | -57.0% | •••• | Bareilly, Uttar Pradesh, India |
| Universal Oncocare Private Limited this company | ₹11.46 Lakh (FY 2022) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Natural 3D Health Clinic Private Limited | ₹11.43 Lakh (FY 2023) | •••• | •••• | -26.0% | •••• | Mumbai, Maharashtra, India |
| Checkpoint Healthcare Private Limited | ₹11.32 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Islampur Spiral C T Scan Private Limited | ₹10.8 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Islampur, Maharashtra, India |
| Diagno Labs Private Limited | ₹10.8 Lakh (FY 2025) | •••• | •••• | -93.0% | •••• | New Delhi, Delhi, India |
| Hari Krishan Diagnostic Private Limited | ₹10.76 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Universal Oncocare by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Universal Oncocare Private Limited
Universal Oncocare has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mishil Sandeep Parikh | Director | 20 Feb 2021 | 5 Years 7 Months | Current |
| Tushar Sambhaji Jadhav Also directs: Gratila Cancer Foundation, Mumbai Breast Care Private Limited | Director | 28 Oct 2020 | 5 Years 11 Months | Current |
| Ninad Vishnu Katdare | Director | 28 Oct 2020 | 5 Years 11 Months | Current |
Charges & Borrowings of Universal Oncocare Private Limited
Universal Oncocare Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Universal Oncocare Private Limited
Employment history and EPFO contributions of people linked to Universal Oncocare.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Universal Oncocare Private Limited
Universal Oncocare Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Mishil Sandeep Parikh was appointed as Director on 20 Feb 2021.
Credit Ratings, Litigation & Regulatory Alerts for Universal Oncocare Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Universal Oncocare Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Universal Oncocare Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Universal Oncocare Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Universal Oncocare Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Universal Oncocare Private Limited
Universal Oncocare is an active private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 28 October 2020 (6+ years old) and is registered under CIN U85100MH2020PTC348921.
Universal Oncocare reported revenue of ₹11.46 Lakh for FY 2022.
Universal Oncocare has 3 current directors:
- Mishil Sandeep Parikh - Director
- Tushar Sambhaji Jadhav - Director
- Ninad Vishnu Katdare - Director
Universal Oncocare reported a net profit of ₹7 Lakh (net margin 61.1%) and EBITDA of ₹8.35 Lakh (EBITDA margin 72.9%) for FY 2022, as per its filed financial statements.
The CIN (Corporate Identification Number) of Universal Oncocare is U85100MH2020PTC348921. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Universal Oncocare was incorporated on 28 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Universal Oncocare by revenue are Doctorslab Medical Services Private Limited, Helixer Health Care Private Limited, DBR Diagnostics Services Private Limited, Noida Diagnostics Private Limited, Physico Radiology Tech Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Mishil Sandeep Parikh was appointed as Director on 20 Feb 2021. Ninad Vishnu Katdare was appointed as Director on 28 Oct 2020. Tushar Sambhaji Jadhav was appointed as Director on 28 Oct 2020.
The registered office of Universal Oncocare is at 2nd Floor Plot 7 Sharda Sadan Swami Gyanjivandas Marg Dadar East, Mumbai, Maharashtra, India – 400014.
Universal Oncocare has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh.
Universal Oncocare operates in the healthcare industry, in the diagnostic centers and pathology labs segment.